NeuroScience Research Center, LLC.

We received a beautiful bouquet from one of our appreciative patients - a heartfelt thank you in the symbolic purple of Alzheimer's awareness. Gestures like these remind us why we do what we do.

Introducing cAPPricorn-1, a clinical trial for people with cerebral amyloid angiopathy (CAA) that is currently enrolling participants.
The cAPPricorn-1 clinical trial is researching an investigational medication called mivelsiran to see if it could be safe and effective in slowing the progression of CAA.

To learn more, please contact us at 330-244-2542 or
visit www.neuroscienceresearchcenterllc.com